scholarly article | Q13442814 |
P2093 | author name string | W Zhao | |
S C Lee | |||
A Casadevall | |||
B C Fries | |||
D L Goldman | |||
R Kennan | |||
P2860 | cites work | An alternative animal model for comparison of treatments for cryptococcal meningitis | Q28369598 |
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. | Q30424017 | ||
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone | Q30449509 | ||
Effect of cytokines on anticryptococcal activity of human microglial cells. | Q33655376 | ||
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. | Q33747538 | ||
Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates | Q33877219 | ||
Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice | Q33997697 | ||
Antibody interactions with the capsule of Cryptococcus neoformans | Q34004832 | ||
Immunoregulation by capsular components of Cryptococcus neoformans. | Q34155052 | ||
Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat | Q34543565 | ||
Phenotypic switching in Cryptococcus neoformans | Q35005269 | ||
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis | Q35411136 | ||
The damage-response framework of microbial pathogenesis | Q35709086 | ||
Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. | Q35773483 | ||
Chronic cryptococcal meningitis: a new experimental model in rabbits | Q35863351 | ||
THE FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. IV. ON THE NATURE AND ORIGIN OF EXTRACELLULAR FLUIDS FOLLOWING CRYPTOCOCCAL POLYSACCHARIDE IMPLANTATION. | Q35869877 | ||
Therapy for cryptococcal meningitis in patients with AIDS | Q35997172 | ||
Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection | Q36042949 | ||
Induction of Capsule Growth inCryptococcus neoformansby Mammalian Serum and CO2 | Q36376167 | ||
Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents | Q36758698 | ||
Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans | Q36958708 | ||
Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome | Q37298560 | ||
Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis | Q38890373 | ||
Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure | Q39512897 | ||
Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage | Q39780336 | ||
Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody | Q39822906 | ||
Sensitivity of sandwich enzyme-linked immunosorbent assay for Cryptococcus neoformans polysaccharide antigen is dependent on the isotypes of the capture and detection antibodies. | Q40007193 | ||
A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage | Q41183035 | ||
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy | Q43690816 | ||
Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications | Q44781962 | ||
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups | Q45068097 | ||
Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group | Q45767647 | ||
Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group | Q45769494 | ||
A simple constant-infusion manometric test for measurement of CSF absorption: II. Clinical studies | Q47773570 | ||
Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia | Q48500734 | ||
Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. | Q48570393 | ||
Cryptococcus neoformans meningitis in the rat. | Q48848654 | ||
Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. | Q52073846 | ||
Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response | Q63247577 | ||
Pulmonary cryptococcosis | Q70060077 | ||
Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group | Q71554754 | ||
Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis | Q73153700 | ||
Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice | Q77552294 | ||
Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors | Q77595479 | ||
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION | Q78467960 | ||
Cryptococcosis | Q78746513 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cryptococcus neoformans | Q131924 |
meningoencephalitis | Q2346415 | ||
P304 | page(s) | 1779-1787 | |
P577 | publication date | 2005-03-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis | |
P478 | volume | 73 |
Q38259355 | Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans |
Q36950154 | Allergen1 regulates polysaccharide structure in Cryptococcus neoformans |
Q33505448 | Antigenic and phenotypic variations in fungi |
Q41780353 | Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans |
Q48807859 | Characterization of BBB permeability in a preclinical model of cryptococcal meningoencephalitis using magnetic resonance imaging. |
Q38904619 | Cryptococcal Disease in HIV-Infected Children. |
Q37395326 | Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis |
Q41588074 | EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans |
Q26801588 | Fungal colonization of the brain: anatomopathological aspects of neurological cryptococcosis |
Q36822539 | Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure |
Q37033075 | Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans |
Q37105673 | Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis. |
Q37600634 | Phenotypic Switching in Fungi |
Q57798551 | Phenotypic Variability Correlates with Clinical Outcome in Isolates Obtained from Botswanan HIV/AIDS Patients |
Q36476671 | Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans |
Q82130569 | Phenotypic switching in Cryptococcus neoformans |
Q37196293 | Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii |
Q37742176 | Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis |
Q41736221 | Ventriculoperitoneal shunts for treating increased intracranial pressure in cryptococcal meningitis with or without ventriculomegaly |
Q37402023 | Virulence in Cryptococcus species |
Search more.